Wenzhi Chen
Overview
Explore the profile of Wenzhi Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
812
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao Y, Wang D, Yang X, Ni L, Lin B, Zhang Y, et al.
Oncol Lett
. 2025 Jan;
29(3):124.
PMID: 39807097
High-intensity focused ultrasound thermal ablation (HIFU) is a novel non-invasive technique in the treatment of liver metastases (LIM) that allows focal destruction and is not affected by dose limits. This...
2.
Chen W, Jiang S, Li C, Li S, Wang J, Xu R
Front Neurol
. 2024 Oct;
15:1417183.
PMID: 39469068
As the COVID-19 pandemic persists, the increasing evidences suggest that the patients with COVID-19 may face the risks of the neurological complications and sequelae. To address this issue, we conducted...
3.
Song Z, Zhang K, Li G, Zhang Z, Zheng J, Ran M, et al.
Heliyon
. 2024 Aug;
10(15):e35298.
PMID: 39170415
Background: The clinical applications of endoscope-assisted transoral release for irreducible atlantoaxial dislocations are limited. This study aimed to investigate the clinical effect and prognostic factors of traditional and endoscope-assisted transoral...
4.
Wu X, Yue X, Liu H, Huang H, Yao D, Guo Y, et al.
Int J Hyperthermia
. 2024 Jul;
41(1):2374874.
PMID: 39053900
Objective: The purpose of this systematic review and meta-analysis was to assess the clinical efficacy and safety of ultrasound (US)-guided high intensity focused ultrasound (HIFU) in the treatment of breast...
5.
Su J, Tong Z, Feng Z, Wu S, Zhou F, Li R, et al.
Int J Biol Macromol
. 2024 Jul;
275(Pt 2):133703.
PMID: 38986982
Despite the high mortality rate associated with sepsis, no specific drugs are available. Decoy receptor 3 (DcR3) is now considered a valuable biomarker and therapeutic target for managing inflammatory conditions....
6.
Su J, Chen W, Zhou F, Li R, Tong Z, Wu S, et al.
mBio
. 2024 May;
15(6):e0052124.
PMID: 38700314
Importance: Sepsis affects millions of hospitalized patients worldwide each year, but there are no sepsis-specific drugs, which makes sepsis therapies urgently needed. Suppression of excessive inflammatory responses is important for...
7.
Wang S, Wang L, Qiu M, Lin Z, Qi W, Lv J, et al.
J Gene Med
. 2024 Apr;
26(4):e3684.
PMID: 38618694
Background: Colon cancer is one of the most common digestive tract malignancies. Although immunotherapy has brought new hope to colon cancer patients, there is still a large proportion of patients...
8.
Chen W, Jiang S, Li S, Li C, Xu R
Neural Regen Res
. 2024 Mar;
19(11):2513-2521.
PMID: 38526287
JOURNAL/nrgr/04.03/01300535-202419110-00031/figure1/v/2024-03-08T184507Z/r/image-tiff Amyotrophic lateral sclerosis is a neurodegenerative disease, and the molecular mechanism underlying its pathology remains poorly understood. However, inflammation is known to play an important role in the development...
9.
Xia Y, Yang M, Xiao X, Tang W, Deng J, Wu L, et al.
Cancer Immunol Immunother
. 2024 Feb;
73(3):50.
PMID: 38349555
Tumor immunotherapy is booming around the world. However, strategies to activate the immune system and alleviate the immunosuppression still need to be refined. Here, we demonstrate for the first time...
10.
Lin B, Fan J, Liu F, Wen Y, Li J, Gao F, et al.
Technol Cancer Res Treat
. 2023 Nov;
22:15330338231218152.
PMID: 38031361
This study aimed to compare the efficacy and safety of docetaxel + trastuzumab + pertuzumab and docetaxel + carboplatin + trastuzumab + pertuzumab for treating HER2-positive breast cancer. HER2-positive breast...